Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles

Toxicology Letters

Volumn 233, Issue 2, 2015, Pages 95-101

  Jones, Kate ^a   Morton, Jackie ^a   Smith, Ian ^a   Jurkschat, Kerstin ^b   Harding, Anne Helen ^a   Evans, Gareth ^a  

^a HEALTH AND SAFETY LABORATORY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Gastrointestinal absorption; Human volunteer study; In vitro; Nanoparticles; Oral dose; Titanium dioxide

Indexed keywords

TITANIUM DIOXIDE NANOPARTICLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELEMENTAL FOOD; EXCRETION; FEMALE; FOOD; GASTROINTESTINAL ABSORPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; MALE; NORMAL HUMAN; PARTICLE SIZE; PARTICLE WEIGHT; PRIORITY JOURNAL; REPRODUCIBILITY; SIMULATION; SOLUBILITY; STOMACH JUICE; WEIGHT;

EID: 84964282447     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.12.005     Document Type: Article

References (13)

1. Böckmann J., Lahl H., Eckert T., Unterhalt B. Titan-blutspiegel vor und nach belastungsversuchen mit titandioxide. Pharmazie 2000, 55(2S):140-143.
2. Bu Q., Yan G., Deng P., Peng F., Lin H., Xu Y., Cao Z., Zhou T., Xue A., Wang Y., Cen X., Zhao Y.L. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2010, 21(March (12)):125105.
3. Cho W.S., Kang B.C., Lee J.K., Jeong J., Che J.H., Seok S.H. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 2013, 10(March):9.
4. EFSA, 2004. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and materials in Contact with Food on a request from the Commission related to the safety in use of rutile titanium dioxide as an alternative to the presently permitted anatase form (Last accessed 29.10.13.). http://www.efsa.europa.eu/EFSA/Scientific_Opinion/opinion_titanium_dioxide1.pdf.
5. EFSA, 2008. Draft opinion of the scientific committee on the potential risks arising from nanoscience and nanotechnologies on food and feed safety (Last accessed 29.10.13.). http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902132298.htm.
6. Environmental Health Criteria, 1982. Environmental Health Criteria 24: Titanium (Last accessed 29.10.13.). http://www.inchem.org/documents/ehc/ehc/ehc24.htm.
7. FAO Nutrition Meetings Report Series 46a, 1969. 150 Titanium dioxide. (Last accessed 29.10.13.). http://www.inchem.org/documents/jecfa/jecmono/v46aje19.htm.
8. Hidalgo I.J., Raub T.J., Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability?. Gastroenterology 1989, 96(3):736-749.
9. Jani P.U., McCarthy D.E., Florence A.T. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int. J. Pharm. 1994, 105:157-168.
10. MacNicoll A, Chaudhry Q, Kelly M, Semizer H, Kramer E, Bouwmeester H (2014 - submitted). A study of the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral intake. J. Nanoparticle Res.
11. Paik S.Y., Zalk D.M., Swuste P. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann. Occup. Hyg. 2008, 52(August (6)):419-428.
12. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168(January (2)):176-185.
13. West, B, and Wyzan, H. (1963) Investigations of the Possible Absorption of Titanium Dioxide from the Gastrointestinal Tract. American Cyanamid Company. Wayne, New Jersey. November 1963. (Unpublished studies, cited in ). http://www.inchem.org/documents/jecfa/jecmono/v46aje19.htm.